Home

Peter Mac scientists have developed a simple blood test that can show which men with the most aggressive type of prostate cancer should respond to conventional therapy, and those who need other options.

A Melbourne-developed treatment decision model - which allows young cancer patients to avoid a hospital stay and instead recover from mild infections at home - is now being adopted by UK hospitals.

The effort to improve diagnosis and treatment for patients with Cancer of the Unknown Primary (CUP) has received a $2.4 million boost from the Medical Research Future Fund.